Jiangsu, China

Wenge Li

This inventor holds 1 USPTO granted patent. Top assignees: Chiral Quest (Suzhou) Co., Ltd., Jiangxi Long Life Bio-Pharmaceutical Co., Ltd.. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wenge Li. Retrieved from https://idiyas.com/inventor/wenge-li-1m6d5v48

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Wenge Li: Innovator in Asymmetric Synthesis**

Introduction

Wenge Li, a prominent inventor based in Jiangsu, China, has made significant contributions to the field of asymmetric synthesis with his innovative processes. With a focus on efficiency and sustainability, Li's work is paving the way for advancements in pharmaceutical preparations.

Latest Patents

Wenge Li holds a notable patent titled "Process for Preparation of N-Boc Biphenyl Alaninol." This patent outlines a unique method for synthesizing (R)-N-Boc biphenyl alaninol, a compound with substantial applications in medicinal chemistry. The process utilizes asymmetric hydrogenation in alcohol solvents, employing specific catalysts to achieve a high yield of the desired product with over 99% purity. The advantages of this process include low cost, safe operation, and minimal environmental impact, making it suitable for industrial scaling.

Career Highlights

Throughout his career, Wenge Li has worked with esteemed organizations, including Chiral Quest (Suzhou) Co., Ltd. and Jiangxi Long Life Bio-pharmaceutical Co., Ltd. His experience in these companies has honed his skills in synthetic chemistry and innovation, allowing him to contribute effectively to the pharmaceutical industry.

Collaborations

Wenge has collaborated with notable colleagues, including Shengwen Wu and Lei Wu, whose collective expertise has undoubtedly enriched the research and development processes in their respective fields. These partnerships exhibit the collaborative nature of scientific advancement and the importance of teamwork in innovation.

Conclusion

Wenge Li continues to be a trailblazer in asymmetric synthesis, contributing valuable inventions to the pharmaceutical sector. His innovative processes and commitment to producing high-purity compounds reflect his dedication to sustainability and efficiency in chemical synthesis. As a respected inventor, Wenge Li's work will likely inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…